Hysteroscopic surgery
Conditions
Interventions
Control group:normal saline
D0.6 group:0.6ug/kg dexmedetomidine
D0.4 group:0.4ug/kg dexmedetomidine
D0.8 group:0.8ug/kg dexmedetomidine
D0.8 group:1.0ug/kg dexmedetomidine
Sponsors
Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: From June 2020 to December 2020, 150 ASA I-II female patients aged 18 to 60 years will be selected from the Affiliated Hospital of North Sichuan Medical College for elective hysteroscopic surgery.
Exclusion criteria
Exclusion criteria: 1. Patients who are allergic to propofol and dexmedetomidine; 2. Patients with heart block; 3. Patients with respiratory and circulatory diseases, endocrine diseases; 4. Patients with liver and kidney dysfunction; 5. Patients who use sedatives and opioids in the near future; 6. Patients with sleep disorders; 7. Patients who abuse drugs or alcohol; 8. Patients with BMI 24.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target controlled infusion concentration of propofol and its response to hysteroscopic dilatation; | — |
Secondary
| Measure | Time frame |
|---|---|
| NIBP;HR;SpO2;Ramsay;RR;pain;operation time;anesthesia time;awake time;the dose of propofol; | — |
Countries
China
Contacts
Public ContactWan Fangjun
Affiliated Hospital of North Sichuan Medical College
Outcome results
None listed